The photodynamic therapy (PDT) market is poised for substantial growth, driven by the increase in number of clinical trials showcasing its effectiveness in treating various medical conditions, particularly cancer.
The surge in minimally invasive surgeries, offering benefits such as reduced pain and shorter hospital stays, further propels market expansion.
Combination therapy, particularly in dermatological treatments, presents lucrative photodynamic therapy market opportunities. PDT is increasingly utilized alongside laser therapy or medications for enhanced efficacy.
Continued advancements in PDT techniques, including targeted drug delivery systems and improved light sources augmenting treatment efficacy and safety is projected to fuel the photodynamic therapy market size.
Hospitals remain key contributors to market expansion, leveraging their comprehensive infrastructure and specialized expertise to meet the growth in patient demand for PDT treatments.
Photodynamic therapy (PDT) offers a promising approach in medical treatment, utilizing photosensitizer drugs and devices to target and destroy diseased tissues.
Photosensitizer drugs include porphyrin derivatives (PD), aminolevulinic acid (ALA), and chlorines. Devices encompass disposable fiber optic light delivery devices (DFOLDD), diode laser, and lamp-based devices.
Photosensitizer drugs are administered through intravenous, oral, and topical routes. Applications of photodynamic therapy span multiple medical fields, including cancer treatment, dermatological conditions, ophthalmology, gastroenterology, gynecology, and infectious diseases.
With its versatility and efficacy, photodynamic therapy is a valuable tool in medical treatment across diverse healthcare settings. In cancer treatment, PDT targets various types of cancers such as basal cell carcinoma, non-small cell lung cancer, and head & neck cancer.
Dermatological conditions such as psoriasis, acne, and actinic keratosis also benefit from PDT. Additionally, PDT finds application in ophthalmology for age-related macular degeneration and other retinal diseases.
| Attribute | Detail |
|---|---|
| Drivers |
|
The rise in number of molecules undergoing early and late phases of clinical trials is bolstering the photodynamic therapy market growth.
With an increasing number of clinical trials assessing the safety and efficacy of photodynamic therapy (PDT) across different settings and patient populations, there is growing evidence supporting its effectiveness in treating various medical conditions, including cancer.
The approval of these molecules following successful clinical trials present lucrative opportunities for manufacturers to enter and expand their presence in the photodynamic therapy market.
This trend reflects a growing interest and investment in PDT research and development, driving market progress and innovation in the field.
The surge in minimally invasive surgeries is fueled by the increase in demand for cardiac surgeries due to the rise in cardiovascular diseases. Additionally, the growth in emphasis on improving physical appearance has led to a rise in cosmetic surgical procedures, contributing to the demand for minimally invasive interventions.
The prevalence of trauma conditions resulting from road accidents and natural disasters propels the adoption of minimally invasive procedures. Furthermore, the increase in obesity cases has led to a rise in bariatric surgeries aimed at managing weight-related health issues.
The adoption of minimally invasive procedures offers several advantages, such as smaller incisions, reduced pain and scarring, fewer complications, and shorter hospital stays, all of which boosts the photodynamic therapy market value.
Advancements in laser technology including diode lasers facilitating faster recovery, contribute to the growth of the photodynamic therapy market by providing innovative and effective treatment options for various medical conditions, including cancer and dermatological disorders.
Research indicates that photodynamic therapy (PDT) is increasingly being employed in combination with laser therapy or medications for enhanced efficacy in treating various skin conditions.
Furthermore, PDT has demonstrated effectiveness in diagnosing and treating malignancies across multiple areas, including lung, esophageal, gastrointestinal, bladder, prostate, head & neck, and oral & skin cancer.
The combination of PDT with other therapies such as metronomic or nanoparticle PDT shows promise in addressing infiltrating growth, a major pathological reason for primary malignant tumors of the bone and soft tissue.
The combination of PDT with electronic magnetic hyperthermia treatment (EMHT) offers several advantages, including the potential to replace conventional tumor surgery and radiotherapy in certain cases.
This highlights the versatility and potential of PDT as a complementary therapy, paving the way for expanded applications and increase in photodynamic therapy market revenue.
The photodynamic therapy market segmentation by product type includes photosensitizer drugs, and devices. The photosensitizer drugs segment is projected to dominate the market. Photodynamic therapy relies on photosensitizers to absorb light energy, initiating the chemical alteration necessary for treatment.
Moreover, the rise in incidence of bone and soft-tissue malignant tumors and the focus on utilizing photodynamic therapy for the diagnosis and treatment of musculoskeletal sarcoma contribute to the growth of this segment.
While the devices segment is also expanding, advancements in PDT techniques, such as targeted drug delivery systems and improved light sources, further enhance the efficacy and safety of treatment, consolidating the dominance of the photosensitizer drugs segment in the photodynamic therapy market.
As per the photodynamic therapy market analysis, by mode of administration, the intravenous segment is projected to dominate during the forecast period.
Photodynamic therapy (PDT) relies on systemic administration of photosensitizers, often via intravenous injection, allowing for uniform distribution throughout the body and preferential accumulation in diseased tissues.
While PDT can be administered via other routes such as topical or oral, intravenous administration remains a preferred choice for its ability to reach deep-seated lesions and provide systemic therapy and for its versatility and efficacy in delivering therapeutic agents to target sites.
The photodynamic therapy industry report highlights the dominance of the cancer application segment, ascribed to PDT's effectiveness in targeting and killing cancer cells with minimal invasiveness.
PDT utilizes photosensitizers, often based on a tetrapyrrole structure, to specifically destroy cancerous cells upon exposure to light. This technique, clinically approved and widely utilized, holds promise in treating various cancer types including lung, bladder, gastrointestinal, and gynecological neoplasms.
| Attribute | Detail |
|---|---|
| Leading Region | North America |
According to the latest photodynamic therapy market forecast, North America, particularly the USA is experiencing steady growth. Substantial investments in healthcare infrastructure, a notable increase in cancer prevalence, regulatory policies & reimbursement scenarios, and ongoing advancements in PDT technology are driving market dynamics in the country.
The USA drives PDT adoption as a viable therapeutic approach across various cancer types such as skin cancer, lung cancer, esophageal cancer, and certain head and neck cancers.
In Asia Pacific, the market is poised for expansion fueled by surge in cancer prevalence, significant demand for PDT, and efforts to strengthen healthcare systems. Increase in awareness of cancer diagnostics and treatment in emerging countries such as India further contributes to market growth by reducing mortality rates and ensuring prompt patient care.
Leading players in the global photodynamic therapy market have adopted strategies such as development of products and disclosing clinical trial data to increase market trust and share.
The photodynamic therapy market is highly competitive and has a strong presence of key players.
GALDERMA, Biofrontera AG, Sun Pharmaceuticals Industries Ltd., LUMIBIRD Groups (Quantel Medical), Modulight Corporation, Quest PharmaTech, Inc., Theralase Technologies Inc., and SUS Advancing Tecchnology CO., Ltd. are the prominent global market manufacturers.
Each of these players have been profiled in the global photodynamic therapy market report based on parameters such as company overview, financial overview, business strategies, product portfolio, business segments, and recent developments.
| Attribute | Detail |
|---|---|
| Market Value in 2022 | US$ 4.5 Bn |
| Forecast (Value) in 2031 | US$ 8.9 Bn |
| Growth Rate (CAGR) | 7.9% |
| Forecast Period | 2023-2031 |
| Historical Data Available for | 2017-2021 |
| Quantitative Units | US$ Bn for Value |
| Market Analysis | It provides segment analysis as well as regional level analysis. Furthermore, qualitative analysis includes drivers, restraints, opportunities, key trends, Porter’s Five Forces analysis, value chain analysis, and key trend analysis. |
| Competition Landscape |
|
| Format | Electronic (PDF) + Excel |
| Market Segmentation |
|
| Regions Covered |
|
| Countries Covered |
|
| Companies Profiled |
|
| Customization Scope | Available upon request |
| Pricing | Available upon request |
It was valued at US$ 4.5 Bn in 2022
It is projected to reach more than US$ 8.9 Bn by 2031
The CAGR is anticipated to be 7.9% from 2023 to 2031
Continuous advancements in light sources, photosensitizing agents, and delivery systems
Based on product type, the photosensitizer drugs segment accounted for major share in 2022
North America is expected to account for major share during the forecast period
GALDERMA, Biofrontera AG, Sun Pharmaceuticals Industries Ltd., LUMIBIRD Groups (Quantel Medical), Modulight Corporation, Quest PharmaTech, Inc., Theralase Technologies Inc., and SUS Advancing Technology Co., Ltd.
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Photodynamic Therapy Market
4. Market Overview
4.1. Introduction
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Photodynamic Therapy Market Analysis and Forecasts, 2017 - 2031
5. Key Insights
5.1. Major Companies in Photodynamic Therapy
5.2. Key Industry Events
5.3. Regulatory Scenario by Region/Globally
5.4. Pipeline Analysis
5.5. Photosensitizers used in Basic Research for Cancer Treatment
6. Global Photodynamic Therapy Market Analysis and Forecasts, By Product Type
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value Forecast By Product Type, 2017 - 2031
6.3.1. Photosensitizer Drugs
6.3.1.1. Porphyrin Derivatives
6.3.1.1.1. Hematoporphyrin Derivative
6.3.1.1.2. Benzoporphyrin Derivative
6.3.1.1.3. Texaphyrins
6.3.1.1.4. Others
6.3.1.2. Aminolevulic acid
6.3.1.3. Chlorines
6.3.1.4. Others
6.3.2. Devices
6.3.2.1. Disposable Fiber Optic Light Delivery Devices
6.3.2.2. Diode Laser
6.3.2.3. Lamp
6.4. Market Attractiveness By Product Type
7. Global Photodynamic Therapy Market Analysis and Forecasts, By Mode of Administration
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Market Value Forecast By Mode of Administration, 2017 - 2031
7.3.1. Intravenous
7.3.2. Oral
7.3.3. Topical
7.4. Market Attractiveness By Mode of Administration
8. Global Photodynamic Therapy Market Analysis and Forecasts, By Application
8.1. Introduction & Definition
8.2. Key Findings / Developments
8.3. Market Value Forecast By Application, 2017 - 2031
8.3.1. Cancer
8.3.1.1. Basal Cell Carcinoma
8.3.1.2. Non-Small Cell Lung Cancer
8.3.1.3. Head & Neck Cancer
8.3.1.4. Others
8.3.2. Dermatological Conditions
8.3.2.1. Psoriasis
8.3.2.2. Acne
8.3.2.3. Actinic Keratosis
8.3.3. Ophthalmology
8.3.3.1. Age-Related Macular Degeneration
8.3.3.2. Retinal Disease
8.3.4. Gastroenterology
8.3.5. Gynecology
8.3.6. Infectious Diseases
8.3.7. Others
8.4. Market Attractiveness By Application
9. Global Photodynamic Therapy Market Analysis and Forecasts, By End-user
9.1. Introduction & Definition
9.2. Key Findings / Developments
9.3. Market Value Forecast By End-user , 2017 - 2031
9.3.1. Hospitals
9.3.2. Cosmetics & Dermatology Clinics
9.3.3. Cancer Treatment Centers
9.3.4. Others
9.4. Market Attractiveness By End-user
10. Global Photodynamic Therapy Market Analysis and Forecasts, By Region
10.1. Key Findings
10.2. Market Value Forecast By Region
10.2.1. North America
10.2.2. Europe
10.2.3. Asia Pacific
10.2.4. Latin America
10.2.5. Middle East & Africa
10.3. Market Attractiveness By Country/Region
11. North America Photodynamic Therapy Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast By Product Type, 2017 - 2031
11.2.1. Photosensitizer Drugs
11.2.1.1. Porphyrin Derivatives
11.2.1.1.1. Hematoporphyrin Derivative
11.2.1.1.2. Benzoporphyrin Derivative
11.2.1.1.3. Texaphyrins
11.2.1.1.4. Others
11.2.1.2. Aminolevulic acid
11.2.1.3. Chlorines
11.2.1.4. Others
11.2.2. Devices
11.2.2.1. Disposable Fiber Optic Light Delivery Devices
11.2.2.2. Diode Laser
11.2.2.3. Lamp
11.3. Market Value Forecast By Mode of Administration, 2017 - 2031
11.3.1. Intravenous
11.3.2. Oral
11.3.3. Topical
11.4. Market Value Forecast By Application, 2017 - 2031
11.4.1. Cancer
11.4.1.1. Basal Cell Carcinoma
11.4.1.2. Non-Small Cell Lung Cancer
11.4.1.3. Head & Neck Cancer
11.4.1.4. Others
11.4.2. Dermatological Conditions
11.4.2.1. Psoriasis
11.4.2.2. Acne
11.4.2.3. Actinic Keratosis
11.4.3. Ophthalmology
11.4.3.1. Age-Related Macular Degeneration
11.4.3.2. Retinal Disease
11.4.4. Gastroenterology
11.4.5. Gynecology
11.4.6. Infectious Diseases
11.4.7. Others
11.5. Market Value Forecast By End-user, 2017 - 2031
11.5.1. Hospitals
11.5.2. Cosmetics & Dermatology Clinics
11.5.3. Cancer Treatment Centers
11.5.4. Others
11.6. Market Value Forecast By Country, 2017 - 2031
11.6.1. U.S.
11.6.2. Canada
11.7. Market Attractiveness Analysis
11.7.1. By Product Type
11.7.2. By Mode of Administration
11.7.3. By Application
11.7.4. By End-user
11.7.5. By Country
12. Europe Photodynamic Therapy Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast By Product Type, 2017 - 2031
12.2.1. Photosensitizer Drugs
12.2.1.1. Porphyrin Derivatives
12.2.1.1.1. Hematoporphyrin Derivative
12.2.1.1.2. Benzoporphyrin Derivative
12.2.1.1.3. Texaphyrins
12.2.1.1.4. Others
12.2.1.2. Aminolevulic acid
12.2.1.3. Chlorines
12.2.1.4. Others
12.2.2. Devices
12.2.2.1. Disposable Fiber Optic Light Delivery Devices
12.2.2.2. Diode Laser
12.2.2.3. Lamp
12.3. Market Value Forecast By Mode of Administration, 2017 - 2031
12.3.1. Intravenous
12.3.2. Oral
12.3.3. Topical
12.4. Market Value Forecast By Application, 2017 - 2031
12.4.1. Cancer
12.4.1.1. Basal Cell Carcinoma
12.4.1.2. Non-Small Cell Lung Cancer
12.4.1.3. Head & Neck Cancer
12.4.1.4. Others
12.4.2. Dermatological Conditions
12.4.2.1. Psoriasis
12.4.2.2. Acne
12.4.2.3. Actinic Keratosis
12.4.3. Ophthalmology
12.4.3.1. Age-Related Macular Degeneration
12.4.3.2. Retinal Disease
12.4.4. Gastroenterology
12.4.5. Gynecology
12.4.6. Infectious Diseases
12.4.7. Others
12.5. Market Value Forecast By End-user, 2017 - 2031
12.5.1. Hospitals
12.5.2. Cosmetics & Dermatology Clinics
12.5.3. Cancer Treatment Centers
12.5.4. Others
12.6. Market Value Forecast By Country, 2017 - 2031
12.6.1. Germany
12.6.2. U.K.
12.6.3. France
12.6.4. Spain
12.6.5. Italy
12.6.6. Rest of Europe
12.7. Market Attractiveness Analysis
12.7.1. By Product Type
12.7.2. By Mode of Administration
12.7.3. By Application
12.7.4. By End-user
12.7.5. By Country
13. Asia Pacific Photodynamic Therapy Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast By Product Type, 2017 - 2031
13.2.1. Photosensitizer Drugs
13.2.1.1. Porphyrin Derivatives
13.2.1.1.1. Hematoporphyrin Derivative
13.2.1.1.2. Benzoporphyrin Derivative
13.2.1.1.3. Texaphyrins
13.2.1.1.4. Others
13.2.1.2. Aminolevulic acid
13.2.1.3. Chlorines
13.2.1.4. Others
13.2.2. Devices
13.2.2.1. Disposable Fiber Optic Light Delivery Devices
13.2.2.2. Diode Laser
13.2.2.3. Lamp
13.3. Market Value Forecast By Mode of Administration, 2017 - 2031
13.3.1. Intravenous
13.3.2. Oral
13.3.3. Topical
13.4. Market Value Forecast By Application, 2017 - 2031
13.4.1. Cancer
13.4.1.1. Basal Cell Carcinoma
13.4.1.2. Non-Small Cell Lung Cancer
13.4.1.3. Head & Neck Cancer
13.4.1.4. Others
13.4.2. Dermatological Conditions
13.4.2.1. Psoriasis
13.4.2.2. Acne
13.4.2.3. Actinic Keratosis
13.4.3. Ophthalmology
13.4.3.1. Age-Related Macular Degeneration
13.4.3.2. Retinal Disease
13.4.4. Gastroenterology
13.4.5. Gynecology
13.4.6. Infectious Diseases
13.4.7. Others
13.5. Market Value Forecast By End-user, 2017 - 2031
13.5.1. Hospitals
13.5.2. Cosmetics & Dermatology Clinics
13.5.3. Cancer Treatment Centers
13.5.4. Others
13.6. Market Value Forecast By Country, 2017 - 2031
13.6.1. China
13.6.2. Japan
13.6.3. India
13.6.4. Australia & New Zealand
13.6.5. Rest of Asia Pacific
13.7. Market Attractiveness Analysis
13.7.1. By Product Type
13.7.2. By Mode of Administration
13.7.3. By Application
13.7.4. By End-user
13.7.5. By Country
14. Latin America Photodynamic Therapy Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Market Value Forecast By Product Type, 2017 - 2031
14.2.1. Photosensitizer Drugs
14.2.1.1. Porphyrin Derivatives
14.2.1.1.1. Hematoporphyrin Derivative
14.2.1.1.2. Benzoporphyrin Derivative
14.2.1.1.3. Texaphyrins
14.2.1.1.4. Others
14.2.1.2. Aminolevulic acid
14.2.1.3. Chlorines
14.2.1.4. Others
14.2.2. Devices
14.2.2.1. Disposable Fiber Optic Light Delivery Devices
14.2.2.2. Diode Laser
14.2.2.3. Lamp
14.3. Market Value Forecast By Mode of Administration, 2017 - 2031
14.3.1. Intravenous
14.3.2. Oral
14.3.3. Topical
14.4. Market Value Forecast By Application, 2017 - 2031
14.4.1. Cancer
14.4.1.1. Basal Cell Carcinoma
14.4.1.2. Non-Small Cell Lung Cancer
14.4.1.3. Head & Neck Cancer
14.4.1.4. Others
14.4.2. Dermatological Conditions
14.4.2.1. Psoriasis
14.4.2.2. Acne
14.4.2.3. Actinic Keratosis
14.4.3. Ophthalmology
14.4.3.1. Age-Related Macular Degeneration
14.4.3.2. Retinal Disease
14.4.4. Gastroenterology
14.4.5. Gynecology
14.4.6. Infectious Diseases
14.4.7. Others
14.5. Market Value Forecast By End-user, 2017 - 2031
14.5.1. Hospitals
14.5.2. Cosmetics & Dermatology Clinics
14.5.3. Cancer Treatment Centers
14.5.4. Others
14.6. Market Value Forecast By Country, 2017 - 2031
14.6.1. Brazil
14.6.2. Mexico
14.6.3. Rest of Latin America
14.7. Market Attractiveness Analysis
14.7.1. By Product Type
14.7.2. By Mode of Administration
14.7.3. By Application
14.7.4. By End-user
14.7.5. By Country
15. Middle East & Africa Photodynamic Therapy Market Analysis and Forecast
15.1. Introduction
15.1.1. Key Findings
15.2. Market Value Forecast By Product Type, 2017 - 2031
15.2.1. Photosensitizer Drugs
15.2.1.1. Porphyrin Derivatives
15.2.1.1.1. Hematoporphyrin Derivative
15.2.1.1.2. Benzoporphyrin Derivative
15.2.1.1.3. Texaphyrins
15.2.1.1.4. Others
15.2.1.2. Aminolevulic acid
15.2.1.3. Chlorines
15.2.1.4. Others
15.2.2. Devices
15.2.2.1. Disposable Fiber Optic Light Delivery Devices
15.2.2.2. Diode Laser
15.2.2.3. Lamp
15.3. Market Value Forecast By Mode of Administration, 2017 - 2031
15.3.1. Intravenous
15.3.2. Oral
15.3.3. Topical
15.4. Market Value Forecast By Application, 2017 - 2031
15.4.1. Cancer
15.4.1.1. Basal Cell Carcinoma
15.4.1.2. Non-Small Cell Lung Cancer
15.4.1.3. Head & Neck Cancer
15.4.1.4. Others
15.4.2. Dermatological Conditions
15.4.2.1. Psoriasis
15.4.2.2. Acne
15.4.2.3. Actinic Keratosis
15.4.3. Ophthalmology
15.4.3.1. Age-Related Macular Degeneration
15.4.3.2. Retinal Disease
15.4.4. Gastroenterology
15.4.5. Gynecology
15.4.6. Infectious Diseases
15.4.7. Others
15.5. Market Value Forecast By End-user, 2017 - 2031
15.5.1. Hospitals
15.5.2. Cosmetics & Dermatology Clinics
15.5.3. Cancer Treatment Centers
15.5.4. Others
15.6. Market Value Forecast By Country, 2017 - 2031
15.6.1. GCC Countries
15.6.2. South Africa
15.6.3. Rest of Middle East & Africa
15.7. Market Attractiveness Analysis
15.7.1. By Product Type
15.7.2. By Mode of Administration
15.7.3. By Application
15.7.4. By End-user
15.7.5. By Country
16. Competition Landscape
16.1. Global Sanitization Robots Market, Company Share Analysis (2022)
16.2. Company Profiles
16.2.1. GALDERMA
16.2.1.1. Company Overview (HQ, Business Segments, Employee Strength)
16.2.1.2. Product Portfolio
16.2.1.3. Financial Overview
16.2.1.4. SWOT Analysis
16.2.1.5. Strategic Overview
16.2.2. Biofrontera AG
16.2.2.1. Company Overview (HQ, Business Segments, Employee Strength)
16.2.2.2. Product Portfolio
16.2.2.3. Financial Overview
16.2.2.4. SWOT Analysis
16.2.2.5. Strategic Overview
16.2.3. Sun Pharmaceuticals Industries Ltd.
16.2.3.1. Company Overview (HQ, Business Segments, Employee Strength)
16.2.3.2. Product Portfolio
16.2.3.3. Financial Overview
16.2.3.4. SWOT Analysis
16.2.3.5. Strategic Overview
16.2.4. LUMIBIRD Groups (Quantel Medical)
16.2.4.1. Company Overview (HQ, Business Segments, Employee Strength)
16.2.4.2. Product Portfolio
16.2.4.3. Financial Overview
16.2.4.4. SWOT Analysis
16.2.4.5. Strategic Overview
16.2.5. Modulight Corporation
16.2.5.1. Company Overview (HQ, Business Segments, Employee Strength)
16.2.5.2. Product Portfolio
16.2.5.3. Financial Overview
16.2.5.4. SWOT Analysis
16.2.5.5. Strategic Overview
16.2.6. Quest PharmaTech, Inc.
16.2.6.1. Company Overview (HQ, Business Segments, Employee Strength)
16.2.6.2. Product Portfolio
16.2.6.3. Financial Overview
16.2.6.4. SWOT Analysis
16.2.6.5. Strategic Overview
16.2.7. Theralase Technologies Inc.
16.2.7.1. Company Overview (HQ, Business Segments, Employee Strength)
16.2.7.2. Product Portfolio
16.2.7.3. Financial Overview
16.2.7.4. SWOT Analysis
16.2.7.5. Strategic Overview
16.2.8. SUS Advancing Tecchnology CO., Ltd.
16.2.8.1. Company Overview (HQ, Business Segments, Employee Strength)
16.2.8.2. Product Portfolio
16.2.8.3. Financial Overview
16.2.8.4. SWOT Analysis
16.2.8.5. Strategic Overview
16.2.9. Others
16.2.9.1. Company Overview (HQ, Business Segments, Employee Strength)
16.2.9.2. Product Portfolio
16.2.9.3. Financial Overview
16.2.9.4. SWOT Analysis
16.2.9.5. Strategic Overview
List of Tables
Table 01: Global Photodynamic Therapy Market Value (US$ Mn) Forecast, by Product Type, 2017-2031
Table 02: Global Photodynamic Therapy Market Value (US$ Mn) Forecast, by Photosensitizer Drugs, 2017-2031
Table 03: Global Photodynamic Therapy Market Value (US$ Mn) Forecast, by Devices, 2017-2031
Table 04: Global Photodynamic Therapy Market Value (US$ Mn) Forecast, by Mode of Administration, 2017-2031
Table 05: Global Photodynamic Therapy Market Value (US$ Mn) Forecast, by Application, 2017-2031
Table 06: Global Photodynamic Therapy Market Value (US$ Mn) Forecast, by Cancer, 2017-2031
Table 07: Global Photodynamic Therapy Market Value (US$ Mn) Forecast, by Dermatological Conditions, 2017-2031
Table 08: Global Photodynamic Therapy Market Value (US$ Mn) Forecast, by Ophthalmology, 2017-2031
Table 09: Global Photodynamic Therapy Market Value (US$ Mn) Forecast, by End-user, 2017-2031
Table 10: Global Photodynamic Therapy Market Value (US$ Mn) Forecast, by Region, 2017-2031
Table 11: North America Photodynamic Therapy Market Value (US$ Mn) Forecast, by Country, 2017-2031
Table 12: North America Photodynamic Therapy Market Value (US$ Mn) Forecast, by Product Type, 2017-2031
Table 13: North America Photodynamic Therapy Market Value (US$ Mn) Forecast, by Product Type, 2017-2031
Table 14: North America Photodynamic Therapy Market Value (US$ Mn) Forecast, by Product Type, 2017-2031
Table 15: North America Photodynamic Therapy Market Value (US$ Mn) Forecast, by Mode of Administration, 2017-2031
Table 16: North America Photodynamic Therapy Market Value (US$ Mn) Forecast, by Application, 2017-2031
Table 17: North America Photodynamic Therapy Market Value (US$ Mn) Forecast, by Application, 2017-2031
Table 18: North America Photodynamic Therapy Market Value (US$ Mn) Forecast, by Application, 2017-2031
Table 19: North America Photodynamic Therapy Market Value (US$ Mn) Forecast, by Application, 2017-2031
Table 20: North America Photodynamic Therapy Market Value (US$ Mn) Forecast, by End-user , 2017-2031
Table 21: Europe Photodynamic Therapy Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
Table 22: Europe Photodynamic Therapy Market Value (US$ Mn) Forecast, by Product Type, 2017-2031
Table 23: Europe Photodynamic Therapy Market Value (US$ Mn) Forecast, by Product Type, 2017-2031
Table 24: Europe Photodynamic Therapy Market Value (US$ Mn) Forecast, by Product Type, 2017-2031
Table 25: Europe Photodynamic Therapy Market Value (US$ Mn) Forecast, by Mode of Administration, 2017-2031
Table 26: Europe Photodynamic Therapy Market Value (US$ Mn) Forecast, by Application, 2017-2031
Table 27: Europe Photodynamic Therapy Market Value (US$ Mn) Forecast, by Application, 2017-2031
Table 28: Europe Photodynamic Therapy Market Value (US$ Mn) Forecast, by Application, 2017-2031
Table 29: Europe Photodynamic Therapy Market Value (US$ Mn) Forecast, by Application, 2017-2031
Table 30: Europe Photodynamic Therapy Market Value (US$ Mn) Forecast, by End-user , 2017-2031
Table 31: Asia Pacific Photodynamic Therapy Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
Table 32: Asia Pacific Photodynamic Therapy Market Value (US$ Mn) Forecast, by Product Type, 2017-2031
Table 33: Asia Pacific Photodynamic Therapy Market Value (US$ Mn) Forecast, by Product Type, 2017-2031
Table 34: Asia Pacific Photodynamic Therapy Market Value (US$ Mn) Forecast, by Product Type, 2017-2031
Table 35: Asia Pacific Photodynamic Therapy Market Value (US$ Mn) Forecast, by Mode of Administration, 2017-2031
Table 36: Asia Pacific Photodynamic Therapy Market Value (US$ Mn) Forecast, by Application, 2017-2031
Table 37: Asia Pacific Photodynamic Therapy Market Value (US$ Mn) Forecast, by Application, 2017-2031
Table 38: Asia Pacific Photodynamic Therapy Market Value (US$ Mn) Forecast, by Application, 2017-2031
Table 39: Asia Pacific Photodynamic Therapy Market Value (US$ Mn) Forecast, by Application, 2017-2031
Table 40: Asia Pacific Photodynamic Therapy Market Value (US$ Mn) Forecast, by End-user, 2017-2031
Table 41: Latin America Photodynamic Therapy Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
Table 42: Latin America Photodynamic Therapy Market Value (US$ Mn) Forecast, by Product Type, 2017-2031
Table 43: Latin America Photodynamic Therapy Market Value (US$ Mn) Forecast, by Product Type, 2017-2031
Table 44: Latin America Photodynamic Therapy Market Value (US$ Mn) Forecast, by Product Type, 2017-2031
Table 45: Latin America Photodynamic Therapy Market Value (US$ Mn) Forecast, by Mode of Administration, 2017-2031
Table 46: Latin America Photodynamic Therapy Market Value (US$ Mn) Forecast, by Application, 2017-2031
Table 47: Latin America Photodynamic Therapy Market Value (US$ Mn) Forecast, by Application, 2017-2031
Table 48: Latin America Photodynamic Therapy Market Value (US$ Mn) Forecast, by Application, 2017-2031
Table 49: Latin America Photodynamic Therapy Market Value (US$ Mn) Forecast, by Application, 2017-2031
Table 50: Latin America Photodynamic Therapy Market Value (US$ Mn) Forecast, by End-user, 2017-2031
Table 51: Middle East & Africa Photodynamic Therapy Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
Table 52: Middle East & Africa Photodynamic Therapy Market Value (US$ Mn) Forecast, by Product Type, 2017-2031
Table 53: Middle East & Africa Photodynamic Therapy Market Value (US$ Mn) Forecast, by Product Type, 2017-2031
Table 54: Middle East & Africa Photodynamic Therapy Market Value (US$ Mn) Forecast, by Product Type, 2017-2031
Table 55: Middle East & Africa Photodynamic Therapy Market Value (US$ Mn) Forecast, by Mode of Administration, 2017-2031
Table 56: Middle East & Africa Photodynamic Therapy Market Value (US$ Mn) Forecast, by Application, 2017-2031
Table 57: Middle East & Africa Photodynamic Therapy Market Value (US$ Mn) Forecast, by Application, 2017-2031
Table 58: Middle East & Africa Photodynamic Therapy Market Value (US$ Mn) Forecast, by Application, 2017-2031
Table 59: Middle East & Africa Photodynamic Therapy Market Value (US$ Mn) Forecast, by Application, 2017-2031
Table 60: Middle East & Africa Photodynamic Therapy Market Value (US$ Mn) Forecast, by End-user, 2017-2031
List of Figures
Figure 01: Global Photodynamic Therapy Market Value (US$ Mn) Forecast, 2017-2031
Figure 02: Global Photodynamic Therapy Market Value Share, by Product Type, 2022
Figure 03: Global Photodynamic Therapy Market Value Share, by Application, 2022
Figure 04: Global Photodynamic Therapy Market Value Share, by Mode of Administration, 2022
Figure 05: Global Photodynamic Therapy Market Value Share, by End-user , 2022
Figure 06: Global Photodynamic Therapy Market Value Share, by Region, 2022
Figure 07: Global Photodynamic Therapy Market Value (US$ Mn) Share Analysis, by Product Type, 2022 and 2031
Figure 08: Global Photodynamic Therapy Market Share Analysis, by Product Type, 2022
Figure 09: Global Photodynamic Therapy Market Share Analysis, by Product Type, 2031
Figure 10: Global Photodynamic Therapy Market Attractiveness Analysis, by Product Type, 2023-2031
Figure 11: Global Photodynamic Therapy Market Value (US$ Mn), by Photosensitizer Drugs, 2017-2031
Figure 12: Global Photodynamic Therapy Market Value Share Analysis, by Photosensitizer Drugs, 2022 and 2031
Figure 13: Global Photodynamic Therapy Market Value (US$ Mn), by Devices, 2017-2031
Figure 14: Global Photodynamic Therapy Market Value Share Analysis, by Devices, 2022 and 2031
Figure 15: Global Photodynamic Therapy Market Value (US$ Mn) Share Analysis, by Mode of Administration, 2022 and 2031
Figure 16: Global Photodynamic Therapy Market Share Analysis, by Mode of Administration, 2022
Figure 17: Global Photodynamic Therapy Market Share Analysis, by Mode of Administration, 2031
Figure 18: Global Photodynamic Therapy Market Attractiveness Analysis, by Mode of Administration, 2023-2031
Figure 19: Global Photodynamic Therapy Market Value (US$ Mn), by Intravenous, 2017-2031
Figure 20: Global Photodynamic Therapy Market Value Share Analysis, by Intravenous, 2022 and 2031
Figure 21: Global Photodynamic Therapy Market Value (US$ Mn), by Oral, 2017-2031
Figure 22: Global Photodynamic Therapy Market Value Share Analysis, by Oral, 2022 and 2031
Figure 23: Global Photodynamic Therapy Market Value (US$ Mn), by Topical, 2017-2031
Figure 24: Global Photodynamic Therapy Market Value Share Analysis, by Topical, 2022 and 2031
Figure 25: Global Photodynamic Therapy Market Value (US$ Mn) Share Analysis, by Application, 2022 and 2031
Figure 26: Global Photodynamic Therapy Market Share Analysis, by Application, 2022
Figure 27: Global Photodynamic Therapy Market Share Analysis, by Application, 2031
Figure 28: Global Photodynamic Therapy Market Attractiveness Analysis, by Application, 2023-2031
Figure 29: Global Photodynamic Therapy Market Value (US$ Mn), by Cancer, 2017-2031
Figure 30: Global Photodynamic Therapy Market Value Share Analysis, by Cancer, 2022 and 2031
Figure 31: Global Photodynamic Therapy Market Value (US$ Mn), by Dermatological Conditions, 2017-2031
Figure 32: Global Photodynamic Therapy Market Value Share Analysis, by Dermatological Conditions, 2022 and 2031
Figure 33: Global Photodynamic Therapy Market Value (US$ Mn), by Ophthalmology, 2017-2031
Figure 34: Global Photodynamic Therapy Market Value Share Analysis, by Ophthalmology, 2022 and 2031
Figure 35: Global Photodynamic Therapy Market Value (US$ Mn), by Gastroenterology, 2017-2031
Figure 36: Global Photodynamic Therapy Market Value Share Analysis, by Gastroenterology, 2022 and 2031
Figure 37: Global Photodynamic Therapy Market Value (US$ Mn), by Gynecology, 2017-2031
Figure 38: Global Photodynamic Therapy Market Value Share Analysis, by Gynecology, 2022 and 2031
Figure 39: Global Photodynamic Therapy Market Value (US$ Mn), by Infectious Disease, 2017-2031
Figure 40: Global Photodynamic Therapy Market Value Share Analysis, by Infectious Disease, 2022 and 2031
Figure 41: Global Photodynamic Therapy Market Value (US$ Mn), by Others, 2017-2031
Figure 42: Global Photodynamic Therapy Market Value Share Analysis, by Others, 2022 and 2031
Figure 43: Global Photodynamic Therapy Market Value (US$ Mn) Share Analysis, by End-user , 2022 and 2031
Figure 44: Global Photodynamic Therapy Market Share Analysis, by End-user , 2022
Figure 45: Global Photodynamic Therapy Market Share Analysis, by End-user , 2031
Figure 46: Global Photodynamic Therapy Market Attractiveness Analysis, by End-user , 2023-2031
Figure 47: Global Photodynamic Therapy Market Value (US$ Mn), by Hospitals, 2017-2031
Figure 48: Global Photodynamic Therapy Market Value Share Analysis, by Hospitals, 2022 and 2031
Figure 49: Global Photodynamic Therapy Market Value (US$ Mn), by Cosmetic & Dermatology Clinics, 2017-2031
Figure 50: Global Photodynamic Therapy Market Value Share Analysis, by Cosmetic & Dermatology Clinics, 2022 and 2031
Figure 51: Global Photodynamic Therapy Market Value (US$ Mn), by Cancer Treatment Centers, 2017-2031
Figure 52: Global Photodynamic Therapy Market Value Share Analysis, by Cancer Treatment Centers, 2022 and 2031
Figure 53: Global Photodynamic Therapy Market Value (US$ Mn), by Others, 2017-2031
Figure 54: Global Photodynamic Therapy Market Value Share Analysis, by Others, 2022 and 2031
Figure 55: Global Photodynamic Therapy Market Value Share Analysis, by Region, 2022 and 2031
Figure 56: Global Photodynamic Therapy Market Share Analysis, by Region, 2022
Figure 57: Global Photodynamic Therapy Market Share Analysis, by Region, 2031
Figure 58: Global Photodynamic Therapy Market Attractiveness Analysis, by Region, 2023-2031
Figure 59: North America Photodynamic Therapy Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2031
Figure 60: North America Photodynamic Therapy Market Value Share Analysis, by Country, 2022 and 2031
Figure 61: North America Photodynamic Therapy Market Attractiveness Analysis, by Country, 2023-2031
Figure 62: North America Photodynamic Therapy Market Value (US$ Mn) Share Analysis, by Product Type, 2022 and 2031
Figure 63: North America Photodynamic Therapy Market Attractiveness Analysis, by Product Type, 2023-2031
Figure 64: North America Photodynamic Therapy Market Value (US$ Mn) Share Analysis, by Mode of Administration, 2022 and 2031
Figure 65: North America Photodynamic Therapy Market Attractiveness Analysis, by Mode of Administration, 2023-2031
Figure 66: North America Photodynamic Therapy Market Value (US$ Mn) Share Analysis, by Application, 2022 and 2031
Figure 67: North America Photodynamic Therapy Market Attractiveness Analysis, by Application, 2023-2031
Figure 68: North America Photodynamic Therapy Market Value (US$ Mn) Share Analysis, by End-user , 2022 and 2031
Figure 69: North America Photodynamic Therapy Market Attractiveness Analysis, by End-user , 2023-2031
Figure 70: Europe Photodynamic Therapy Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2031
Figure 71: Europe Photodynamic Therapy Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
Figure 72: Europe Photodynamic Therapy Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
Figure 73: Europe Photodynamic Therapy Market Value (US$ Mn) Share Analysis, by Product Type, 2022 and 2031
Figure 74: Europe Photodynamic Therapy Market Attractiveness Analysis, by Product Type, 2023-2031
Figure 75: Europe Photodynamic Therapy Market Value (US$ Mn) Share Analysis, by Mode of Administration, 2022 and 2031
Figure 76: Europe Photodynamic Therapy Market Attractiveness Analysis, by Mode of Administration, 2023-2031
Figure 77: Europe Photodynamic Therapy Market Value (US$ Mn) Share Analysis, by Application, 2022 and 2031
Figure 78: Europe Photodynamic Therapy Market Attractiveness Analysis, by Application, 2023-2031
Figure 79: Europe Photodynamic Therapy Market Value (US$ Mn) Share Analysis, by End-user , 2022 and 2031
Figure 80: Europe Photodynamic Therapy Market Attractiveness Analysis, by End-user , 2023-2031
Figure 81: Asia Pacific Photodynamic Therapy Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2031
Figure 82: Asia Pacific Photodynamic Therapy Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
Figure 83: Asia Pacific Photodynamic Therapy Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
Figure 84: Asia Pacific Photodynamic Therapy Market Value (US$ Mn) Share Analysis, by Product Type, 2022 and 2031
Figure 85: Asia Pacific Photodynamic Therapy Market Attractiveness Analysis, by Product Type, 2023-2031
Figure 86: Asia Pacific Photodynamic Therapy Market Value (US$ Mn) Share Analysis, by Mode of Administration, 2022 and 2031
Figure 87: Asia Pacific Photodynamic Therapy Market Attractiveness Analysis, by Mode of Administration, 2023-2031
Figure 88: Asia Pacific Photodynamic Therapy Market Value (US$ Mn) Share Analysis, by Application, 2022 and 2031
Figure 89: Asia Pacific Photodynamic Therapy Market Attractiveness Analysis, by Application, 2023-2031
Figure 90: Asia Pacific Photodynamic Therapy Market Value (US$ Mn) Share Analysis, by End-user , 2022 and 2031
Figure 91: Asia Pacific Photodynamic Therapy Market Attractiveness Analysis, by End-user , 2023-2031
Figure 92: Latin America Photodynamic Therapy Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2031
Figure 93: Latin America Photodynamic Therapy Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
Figure 94: Latin America Photodynamic Therapy Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
Figure 95: Latin America Photodynamic Therapy Market Value (US$ Mn) Share Analysis, by Product Type, 2022 and 2031
Figure 96: Latin America Photodynamic Therapy Market Attractiveness Analysis, by Product Type, 2023-2031
Figure 97: Latin America Photodynamic Therapy Market Value (US$ Mn) Share Analysis, by Mode of Administration, 2022 and 2031
Figure 98: Latin America Photodynamic Therapy Market Attractiveness Analysis, by Mode of Administration, 2023-2031
Figure 99: Latin America Photodynamic Therapy Market Value (US$ Mn) Share Analysis, by Application, 2022 and 2031
Figure 100: Latin America Photodynamic Therapy Market Attractiveness Analysis, by Application, 2023-2031
Figure 101: Latin America Photodynamic Therapy Market Value (US$ Mn) Share Analysis, by End-user , 2022 and 2031
Figure 102: Latin America Photodynamic Therapy Market Attractiveness Analysis, by End-user , 2023-2031
Figure 103: Middle East & Africa Photodynamic Therapy Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2031
Figure 104: Middle East & Africa Photodynamic Therapy Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
Figure 105: Middle East & Africa Photodynamic Therapy Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
Figure 106: Middle East & Africa Photodynamic Therapy Market Value (US$ Mn) Share Analysis, by Product Type, 2022 and 2031
Figure 107: Middle East & Africa Photodynamic Therapy Market Attractiveness Analysis, by Product Type, 2023-2031
Figure 108: Middle East & Africa Photodynamic Therapy Market Value (US$ Mn) Share Analysis, by Mode of Administration, 2022 and 2031
Figure 109: Middle East & Africa Photodynamic Therapy Market Attractiveness Analysis, by Mode of Administration, 2023-2031
Figure 110: Middle East & Africa Photodynamic Therapy Market Value (US$ Mn) Share Analysis, by Application, 2022 and 2031
Figure 111: Middle East & Africa Photodynamic Therapy Market Attractiveness Analysis, by Application, 2023-2031
Figure 112: Middle East & Africa Photodynamic Therapy Market Value (US$ Mn) Share Analysis, by End-user , 2022 and 2031
Figure 113: Middle East & Africa Photodynamic Therapy Market Attractiveness Analysis, by End-user , 2023-2031
Copyright © Transparency Market Research, Inc. All Rights reserved
Trust Online
Photodynamic Therapy Market
